PBSS-San Francisco Bay – Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies: Small Molecules, Peptides, Nucleotides, and Other Modalities

We look forward to seeing you at the upcoming PBSS-San Francisco Workshop!

Exhibitor & Presenter

Presentation: Determination of β-Hydroxydeoxycholic Acid and its Glycine and Taurine Conjugates for Exploratory Biomarker Assessment of Potential Drug-Drug Interactions
Presented by Sarah A. Oehm, PhD, Senior Scientist and Principal Investigator, Alturas Analytics

About the Symposium
This symposium will highlight emerging strategies and practical considerations in drug metabolism, bioanalysis, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides, peptides, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. Expert speakers from industry will share real-world case studies and methodological advances addressing in vitro ADME characterization and innovative LC–MS bioanalytical strategies across a range of therapeutic modalities. Topics will include modality-specific challenges, comparison of novel modalities with small molecules, and lessons learned from both cleavable and non-cleavable ADC linker systems.

Contact us to schedule a meeting with the Alturas Team.